United States · FDA National Drug Code directory

Levocarnitine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71656-016_30a343cc-caab-d417-e063-6394a90ad77b
Product NDC
71656-016
Form
SOLUTION
Composition / generic term
Levocarnitine Oral
Labeler
Saptalis Pharmaceuticals, LLC
Marketing category
ANDA
Marketing start / end (source format)
20240221
Source listing expiry
20261231

Source-listed ingredients

  • LEVOCARNITINE — 1 g/10mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CUP, UNIT-DOSE in 1 TRAY (71656-016-01) / 5 mL in 1 CUP, UNIT-DOSE (71656-016-05) · 71656-016-01
  • 100 CUP, UNIT-DOSE in 1 TRAY (71656-016-02) / 10 mL in 1 CUP, UNIT-DOSE (71656-016-10) · 71656-016-02
  • 118 mL in 1 BOTTLE (71656-016-04) · 71656-016-04
  • 50 CUP, UNIT-DOSE in 1 TRAY (71656-016-50) / 5 mL in 1 CUP, UNIT-DOSE (71656-016-05) · 71656-016-50
  • 50 CUP, UNIT-DOSE in 1 TRAY (71656-016-51) / 10 mL in 1 CUP, UNIT-DOSE (71656-016-10) · 71656-016-51

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →